Literature DB >> 8261769

Epidemiology of nosocomial Clostridium difficile infection.

M H Samore1.   

Abstract

C. difficile is a frequent cause of nosocomial diarrhea and is associated with substantial morbidity. C. difficile carriage may arise either from overgrowth of endogenous organisms or from exogenous acquisition. Within hospitals, asymptomatically colonized patients typically outnumber symptomatic patients by a ratio of approximately 3:1. Patient-to-patient transmission of C. difficile has been well documented in studies of nosocomial outbreaks, utilizing typing methods to supplement epidemiologic investigations. The mechanisms and frequency of transmission probably vary between institutions, but contamination of environmental surfaces and personnel hand carriage both appear to be important. Nosocomial C. difficile infection can be remarkably difficult to control, particularly after it becomes endemic in an institution. Policies targeting both environmental contamination and personnel hand-washing/glove use practices may be most successful. Prophylaxis of C. difficile diarrhea in high-risk patients on antibiotics may also have merit if an effective and safe biologic agent can be identified. Asymptomatically colonized patients should not be treated because they are at low risk for the development of diarrhea and because further antibiotic treatment may prolong the carrier state.

Entities:  

Mesh:

Year:  1993        PMID: 8261769

Source DB:  PubMed          Journal:  Compr Ther        ISSN: 0098-8243


  5 in total

Review 1.  Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

2.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Diarrhea recurrence in patients with Clostridium difficile-associated diarrhea: Role of concurrent antibiotics.

Authors:  M Alfa; G Harding; A Ronald; R Light; N Macfarlane; N Olson; P Degagne; K Kasdorf; A Simor; K Macdonald; L Louie
Journal:  Can J Infect Dis       Date:  1999-07

4.  In vitro and in vivo activities of nitazoxanide against Clostridium difficile.

Authors:  C S McVay; R D Rolfe
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients.

Authors:  Stojanovic Predrag; Kocic Branislava; Stojanovic Miodrag; Miljkovic-Selimovic Biljana; Tasic Suzana; Miladinovic-Tasic Natasa; Babic Tatjana
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.